Clinical Trial Update: oncoFISH Cervical Test for Detection of 3q26 Region Gain

View source ↗

Summary

Clinical trial update on the oncoFISH Cervical Test for detecting 3q26 region gain in cervical cancer and low-grade cervical lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Snippet

Sponsor: Ikonisys, Inc. | Conditions: Cervical Cancer, LSIL | Status: UNKNOWN